HK1087026A1 - Use of indazole derivtives for the treatment of neuropathic pain - Google Patents

Use of indazole derivtives for the treatment of neuropathic pain

Info

Publication number
HK1087026A1
HK1087026A1 HK06107280A HK06107280A HK1087026A1 HK 1087026 A1 HK1087026 A1 HK 1087026A1 HK 06107280 A HK06107280 A HK 06107280A HK 06107280 A HK06107280 A HK 06107280A HK 1087026 A1 HK1087026 A1 HK 1087026A1
Authority
HK
Hong Kong
Prior art keywords
derivtives
indazole
treatment
neuropathic pain
neuropathic
Prior art date
Application number
HK06107280A
Other languages
English (en)
Inventor
Angelo Guglielmotti
Lorenzo Polenzani
Alessandra Alisi
Nicola Cazzolla
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1087026A1 publication Critical patent/HK1087026A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
HK06107280A 2003-07-18 2006-06-28 Use of indazole derivtives for the treatment of neuropathic pain HK1087026A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001468A ITMI20031468A1 (it) 2003-07-18 2003-07-18 Farmaco ativo nel dolore neuropatico
PCT/EP2004/007635 WO2005013989A1 (en) 2003-07-18 2004-07-08 Use of indazole derivatives for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
HK1087026A1 true HK1087026A1 (en) 2006-10-06

Family

ID=34131194

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107280A HK1087026A1 (en) 2003-07-18 2006-06-28 Use of indazole derivtives for the treatment of neuropathic pain

Country Status (22)

Country Link
US (1) US7638534B2 (zh)
EP (1) EP1646387B1 (zh)
JP (1) JP4881729B2 (zh)
KR (1) KR101073993B1 (zh)
CN (1) CN100427089C (zh)
AR (1) AR045994A1 (zh)
AT (1) ATE345134T1 (zh)
AU (1) AU2004262878B2 (zh)
CA (1) CA2526052C (zh)
DE (1) DE602004003251T2 (zh)
DK (1) DK1646387T3 (zh)
EA (1) EA008144B1 (zh)
ES (1) ES2275232T3 (zh)
GE (1) GEP20084343B (zh)
HK (1) HK1087026A1 (zh)
IL (1) IL172101A (zh)
IT (1) ITMI20031468A1 (zh)
MX (1) MXPA06000651A (zh)
PL (1) PL1646387T3 (zh)
PT (1) PT1646387E (zh)
UA (1) UA81051C2 (zh)
WO (1) WO2005013989A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062230A1 (it) 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
AU2009276082B2 (en) 2008-07-29 2014-01-23 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116024A1 (en) * 1991-08-20 1993-03-04 Francis David King 5-ht4 receptor antagonists
JP3294611B2 (ja) * 1991-09-12 2002-06-24 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４レセプター・アンタゴニスト
MA22647A1 (fr) * 1991-09-14 1993-04-01 Smithkline Beecham Plc Procede de preparation d'un ester ou d'un amide d'un nouveau produit .
GB9120628D0 (en) 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
ES2132223T3 (es) 1992-03-12 1999-08-16 Smithkline Beecham Plc Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
DE10132746A1 (de) * 2001-07-05 2003-02-06 Gruenenthal Gmbh Substituierte 1-Phenethylpiperidinverbindungen
US6624162B2 (en) * 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators
US20060135516A1 (en) * 2002-08-10 2006-06-22 Astex Technology, Ltd. 3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) * 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.

Also Published As

Publication number Publication date
GEP20084343B (en) 2008-03-25
PL1646387T3 (pl) 2007-03-30
KR101073993B1 (ko) 2011-10-17
JP2009513544A (ja) 2009-04-02
UA81051C2 (en) 2007-11-26
DE602004003251T2 (de) 2007-05-10
MXPA06000651A (es) 2006-03-30
IL172101A (en) 2011-08-31
CA2526052C (en) 2011-08-30
WO2005013989A1 (en) 2005-02-17
DE602004003251D1 (de) 2006-12-28
CA2526052A1 (en) 2005-02-17
EP1646387A1 (en) 2006-04-19
AR045994A1 (es) 2005-11-23
PT1646387E (pt) 2007-01-31
ATE345134T1 (de) 2006-12-15
US20060183775A1 (en) 2006-08-17
EA200600271A1 (ru) 2006-06-30
ES2275232T3 (es) 2007-06-01
CN1809356A (zh) 2006-07-26
AU2004262878B2 (en) 2009-12-17
AU2004262878A1 (en) 2005-02-17
US7638534B2 (en) 2009-12-29
EA008144B1 (ru) 2007-04-27
JP4881729B2 (ja) 2012-02-22
EP1646387B1 (en) 2006-11-15
IL172101A0 (en) 2009-02-11
CN100427089C (zh) 2008-10-22
ITMI20031468A1 (it) 2005-01-19
KR20060033006A (ko) 2006-04-18
DK1646387T3 (da) 2007-03-19

Similar Documents

Publication Publication Date Title
IL185485A0 (en) Use of pde7 inhibitors for the treatment of neuropathic pain
GB0213869D0 (en) The treatment of pain
HK1087026A1 (en) Use of indazole derivtives for the treatment of neuropathic pain
GB0330049D0 (en) The treatment of neuropathic pain conditions
AU2003259074A8 (en) Gal3 antagonists for the treatment of neuropathic pain
ZA200707147B (en) Use of PDE7 inhibitors for the treatment of neuropathic pain
EP1687275A4 (en) PYRIDINE-4-YLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF NEUROPATHIC PAIN
HK1087027A1 (en) Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain
GB0300428D0 (en) Medical treatment
SI1646387T1 (sl) Uporaba indazolnih derivatov za zdravljenje nevropaticne bolecine
GB0307472D0 (en) Medical treatment
GB0325957D0 (en) The treatment of pain
GB0322015D0 (en) The treatment of neuropathic pain conditions
GB0306165D0 (en) Medical treatment
GB0219706D0 (en) The treatment of neuropathic pain
GB0322014D0 (en) The treatment of pain
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0216978D0 (en) The treatment of pain
GB0418556D0 (en) The treatment of pain
GB0415267D0 (en) The treatment of pain
GB0213870D0 (en) The treatment of pain conditions
GB0310463D0 (en) Therapeutic agents for the treatment of bone conditions
GB0325259D0 (en) Therapeutic agents for the treatment of bone conditions
GB0306583D0 (en) Medical treatment
GB0306651D0 (en) Medical treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180708